Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Zura Bio Limited before investing.

In this article, we go over a few key elements for understanding Zura Bio Limited’s stock price such as:

• Zura Bio Limited’s current stock price and volume
• Why Zura Bio Limited’s stock price changed recently
• Upgrades and downgrades for ZURA from analysts
• ZURA’s stock price momentum as measured by its relative strength

About Zura Bio Limited (ZURA)

Before we jump into Zura Bio Limited’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.

Want to learn more about Zura Bio Limited’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Zura Bio Limited.

Zura Bio Limited’s Stock Price as of Market Close

As of September 04, 2026, 4:00 PM, CST, Zura Bio Limited’s stock price was $6.230.

Zura Bio Limited is up 5.95% from its previous closing price of $5.880.

During the last market session, Zura Bio Limited’s stock traded between $5.630 and $6.260. Currently, there are approximately 126.80 million shares outstanding for Zura Bio Limited.

Zura Bio Limited’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Zura Bio Limited Stock Price History

Zura Bio Limited’s (ZURA) price is currently up 12.45% so far this month.

During the month of September, Zura Bio Limited’s stock price has reached a high of $6.260 and a low of $5.390.

Over the last year, Zura Bio Limited has hit prices as high as $7.440 and as low as $1.880. Year to date, Zura Bio Limited’s stock is up 18.89%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Zura Bio Limited Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 04, 2026, there was 1 analyst who downgraded Zura Bio Limited’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Zura Bio Limited’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Zura Bio Limited’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Zura Bio Limited (ZURA) by visiting AAII Stock Evaluator.

Relative Price Strength of Zura Bio Limited

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 04, 2026, Zura Bio Limited has a weighted four-quarter relative price strength of 46.93%, which translates to a Momentum Score of 98 and is considered to be Very Strong.

Want to learn more about how Zura Bio Limited is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Zura Bio Limited Stock Price: Bottom Line

As of September 4, 2026, Zura Bio Limited’s stock price is $6.230, which is up 5.95% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Zura Bio Limited stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.